Ophthalmic Business News

WASHINGTON — Growth in the ophthalmic device market will accelerate over the next 2 to 3 years due to the reduction of COVID-19-driven backlogs, according to a presenter here.

WASHINGTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Greg Kunst, president and CEO of Aurion Biotech, discusses a survey showing the prevalence of diagnosed yet untreated corneal endothelial disease.

WASHINGTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Chuck Hess, vice president and general manager of Bausch + Lomb Surgical, discusses the recent Xipere approval as well as the enVista toric calculator.

Join White as he discusses the burden cataract post-operative regimens place on both patients and staff, and ways to “stop the madness.” He also gives a history of cataract post-op and the breakthroughs that led to today’s most common regimens.

In this video, Gary W. Herschman, JD, discusses the increase in physician transactions with private equity firms and four major reasons for this trend.

In this episode, Laura M. Periman, MD, talks with Vandana C. Reddy, MD, and Rupa K. Wong, MD, about the challenges female surgeons face, how to navigate some of the societal dualities of being a woman leader and more.

When it comes to online reviews, physicians should consider online reviews before advertising as reviews not only improve physician visibility online, but also reassure patients about the care they will receive prior to their visit.

Aurion Biotech has raised $120 million in financing, led by Deerfield Management, according to a press release.

The first quarter of 2022 has served as a stark reminder that financial markets can decline — and decline quickly.

For those of you who don’t know, a marketing funnel is a process that a prospect goes through on their path to purchase. It is accompanied by a sales pipeline, but that topic will be explained in a later post.